J&J Raises Cornucopia Of Issues In $4.69B Ovarian-Cancer Asbestos Award Challenge
ST. LOUIS — Johnson & Johnson kicked off a wide-reaching challenge to a $4.69 billion asbestos-talc ovarian cancer verdict by calling joint trial of 22 women’s claims covering 32 years of...To view the full article, register now.
Already a subscriber? Click here to view full article